J Jassem
Impact in
-
- Menopause: Health Impacts and Treatments
-
- Cancer Risks and Factors
- Cancer survivorship and care
Papers in
-
- Lung Cancer Diagnosis and Treatment 3
- Lung Cancer Treatments and Mutations 3
- Occupational and environmental lung diseases 2
- Pleural and Pulmonary Diseases 2
- Oncology 9
- Peptidase Inhibition and Analysis 3
- Cancer Immunotherapy and Biomarkers 3
- Lung Cancer Research Studies 2
- Co-authors
- Mats Hammar (1 shared paper)E. Kumpulainen (1 shared paper)Janusz Jaśkiewicz (1 shared paper)C.-M. Rudenstam (1 shared paper)Hans E. Fjøsne (1 shared paper)R. Arriagada (1 shared paper)Lars Holmberg (1 shared paper)Marit Holmqvist (1 shared paper)
- Journals
- Lung Cancer (2 papers)European Journal of Cancer (2 papers)Biomarkers (1 paper)JNCI Journal of the National Cancer Institute (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- PolandSwedenUnited States
In The Last Decade
J Jassem
22 papers receiving 297 citations
Peers
Comparison fields: 5 of 51
- Endocrinology, Diabetes and Metabolism 118
- Oncology 155
- Genetics 140
- Obstetrics and Gynecology 35
- Reproductive Medicine 36
Countries citing papers authored by J Jassem
This map shows the geographic impact of J Jassem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Jassem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Jassem more than expected).
Fields of papers citing papers by J Jassem
This network shows the impact of papers produced by J Jassem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Jassem. The network helps show where J Jassem may publish in the future.
Co-authors
The 25 scholars most cited alongside J Jassem, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 215 | |
| 2 | 1996 | 14 | |
| 3 | 2003 | 13 | |
| 4 | Expression of vascular endothelial growth factor (VEGF) and its receptor FLK-1 in non-small cell lung cancer (NSCLC)--a preliminary report. | 2001 | 12 |
| 5 | 2009 | 11 | |
| 6 | Phase II study of 4'-epi-doxorubicin in patients with untreated, extensive small cell lung cancer. South-East European Oncology Group (SEEOG). | 1990 | 7 |
| 7 | 2006 | 7 | |
| 8 | 2003 | 7 | |
| 9 | The incidence of chronic obstructive pulmonary disease in advanced non-small cell lung cancer patients | 2007 | 5 |
| 10 | 2006 | 5 | |
| 11 | The occurrence of cerebellar hemangioblastoma in numerous first degree relatives with von Hippel-Lindau disease. | 1999 | 4 |
| 12 | 2007 | 3 | |
| 13 | GENE EXPRESSION SIGNATURE IS A POTENTIAL PREDICTIVE FACTOR FOR EFFICACY OF MAGE-A3 ANTIGEN-SPECIFIC CANCER IMMUNOTHERAPEUTIC (ASCI) AS ADJUVANT THERAPY IN RESECTED STAGE IB/II NON-SMALL CELL LUNG CANCER (NSCLC) | 2008 | 2 |
| 14 | [Late recurrence of malignant tumours 20 years after diagnosis and treatment]. | 2007 | 2 |
| 15 | [Analysis of prognostic factors for long term survival in patients with small cell lung cancer]. | 1994 | 2 |
| 16 | 2001 | 2 | |
| 17 | [Autoantibodies in patients with malignant tumors]. | 1980 | 2 |
| 18 | [Evaluation of the prognostic significance of P53 mutation in patients with non-small cell lung cancer]. | 1998 | 1 |
| 19 | [Platinum-based chemotherapy in renal transplant recipients with malignancies: a case report and review of literature]. | 1998 | 1 |
| 20 | Expression of thymidylate synthase (TYMS) and Insulin growth factor 1 (IGF1) in completely-resected NSCLC patients: associations with histological subtype and prognosis | 2009 | 1 |
About J Jassem
J Jassem is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Surgery, having authored 23 papers that have together received 318 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Lung Cancer Treatments and Mutations (3 papers), Occupational and environmental lung diseases (2 papers), Pleural and Pulmonary Diseases (2 papers), Cancer therapeutics and mechanisms (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (118 citations), Oncology (155 citations), Genetics (140 citations), Obstetrics and Gynecology (35 citations) and Reproductive Medicine (36 citations). J Jassem has collaborated with scholars based in Poland, Sweden and United States. Frequent co-authors include Mats Hammar, E. Kumpulainen, Janusz Jaśkiewicz, C.-M. Rudenstam, Hans E. Fjøsne, R. Arriagada, Lars Holmberg, Marit Holmqvist, Ole Erik Iversen and O Peralta. Their work appears in journals such as Lung Cancer, European Journal of Cancer, Biomarkers, JNCI Journal of the National Cancer Institute and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.